← back to search

Mel Β. Feany

The Ohio State University Wexner Medical Center ·
Area of research
Neurology · Physiology
Research interest
Research interests include Biology, Neurodegeneration, Neuroscience, Tauopathy, Disease, and Medicine.
h-index
citations
2,799
works
15
NIH funding
primary concept
email

Recent publications

An integrative systems-biology approach defines mechanisms of Alzheimer’s disease neurodegeneration
Nature Communications 2025cited by 17position: middledoi
Transcriptional programs mediating neuronal toxicity and altered glial–neuronal signaling in a <i>Drosophila</i> knock-in tauopathy model
Genome Research 2024cited by 9position: lastdoi
The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability
Cell 2022cited by 165position: middledoi
Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
npj Parkinson s Disease 2020cited by 29position: lastdoi
Tissue and cellular rigidity and mechanosensitive signaling activation in Alexander disease
Nature Communications 2018cited by 62position: lastdoi
α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton
Neuron 2017cited by 235position: lastdoi
Defective Phagocytic Corpse Processing Results in Neurodegeneration and Can Be Rescued by TORC1 Activation
Journal of Neuroscience 2016cited by 60position: middledoi
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
Acta Neuropathologica 2015cited by 522position: middledoi
Lamin Dysfunction Mediates Neurodegeneration in Tauopathies
Current Biology 2015cited by 236position: lastdoi
Tau promotes neurodegeneration through global chromatin relaxation
Nature Neuroscience 2014cited by 495position: lastdoi
p53 prevents neurodegeneration by regulating synaptic genes
Proceedings of the National Academy of Sciences 2014cited by 85position: lastdoi
Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms
Human Molecular Genetics 2013cited by 178position: lastdoi
Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo
Neuron 2012cited by 380position: lastdoi
Alexander Disease
Journal of Neuroscience 2012cited by 252position: middledoi
A genetic basis for the variable effect of smoking/nicotine on Parkinson’s disease
The Pharmacogenomics Journal 2012cited by 74position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ernest Fraenkel · Massachusetts Institute of Technology3 papers (2018–2025)Bess Frost · Allen Institute for Brain Science3 papers (2014–2015) · 2 papers (2024–2025)Xianjun Dong · Yale Cancer Center2 papers (2024–2025)Albee Messing · University of Wisconsin System2 papers (2012–2018)Souvarish Sarkar · University of Rochester Medical Center2 papers (2020–2024)Matthew Leventhal · Broad Institute2 papers (2024–2025)Cyrus P. Zabetian · University of Washington1 papers (2012–2012)Michael Brenner · University of Alabama at Birmingham1 papers (2012–2012)Pritam Ganguly · University of California, Santa Barbara1 papers (2012–2012)Clemens R. Scherzer · Yale University1 papers (2025–2025)Abby L. Olsen · University of Pittsburgh Medical Center1 papers (2020–2020)James E. Goldman · Columbia University1 papers (2012–2012)Lori B. Chibnik · Harvard University1 papers (2013–2013)Srikant Rangaraju · Yale University1 papers (2020–2020)Kimberly McCall · Boston University1 papers (2016–2016)Jeffrey R. Jones · Salk Institute for Biological Studies1 papers (2018–2018)Michael K. Lee · University of Minnesota1 papers (2017–2017)Peter J. Park · Broad Institute1 papers (2014–2014) · 1 papers (2013–2013)